⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15349300 | 0.77 | — | — | |
| SCHEMBL31207085 | 0.75 | HCAR1 (0.31) | — | |
| SCHEMBL895809 | 0.75 | — | — | |
| SCHEMBL6272976 | 0.66 | — | — | |
| SCHEMBL18886653 | 0.64 | KDM4E (0.37) | — | |
| SCHEMBL16660466 | 0.64 | KDM4E (0.35) | — | |
| SCHEMBL11739358 | 0.62 | KDM4E (0.36) | — | |
| SCHEMBL28614043 | 0.62 | KDM4E (0.36) | — | |
| SCHEMBL17955319 | 0.60 | KDM4E (0.32) | — | |
| SCHEMBL59379 | 0.59 | KDM4E (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TUDAG TU DRESDEN AKTIENGESELLSCHAFT (DE) | 2026-03-31 | — | — | US | disclosed |